Lv1
40 积分 2025-10-29 加入
The past, present and future of de novo protein design
6天前
已完结
DualGPT-AB: a dual-stage generative optimization framework for therapeutic antibody design
6天前
已完结
GalaxyDock-DL: Protein–Ligand Docking by Global Optimization and Neural Network Energy
1个月前
已完结
PD-1 x CD2 cis-acting bispecific antibodies are potent PD-1 agonists that restrain human T cell responses independent of Fc-receptor engagement 4271
4个月前
已完结
Safety and pharmacokinetics of SOR102, an oral bispecific inhibitor of TNF and interleukin-23 in healthy participants and patients with ulcerative colitis: a first-in-human, double-blind, randomised, placebo-controlled, phase 1 trial
4个月前
已完结
Surface Charge and Solvent Exposure Dictate the pH-Dependent Viscosity of Therapeutic Antibodies
4个月前
已完结
Simulating 500 million years of evolution with a language model
5个月前
已完结
AI-driven antibody design with generative diffusion models: current insights and future directions
5个月前
已完结
Evolutionary-scale prediction of atomic-level protein structure with a language model
6个月前
已完结
皖公网安备34019202002308
